{"id":617953,"date":"2025-12-23T13:38:14","date_gmt":"2025-12-23T13:38:14","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/617953\/"},"modified":"2025-12-23T13:38:14","modified_gmt":"2025-12-23T13:38:14","slug":"usa-les-valeurs-a-suivre-a-wall-street-actualise-23-12-2025-a-1354","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/617953\/","title":{"rendered":"USA-Les valeurs \u00e0 suivre \u00e0 Wall Street (actualis\u00e9) &#8211; 23\/12\/2025 \u00e0 13:54"},"content":{"rendered":"<p>\n (Actualis\u00e9 avec contrats \u00e0 terme sur indices, cours en<br \/>\navant-Bourse, d\u00e9taillants am\u00e9ricains)\n<\/p>\n<p>\n Principales valeurs \u00e0 suivre mardi \u00e0 Wall Street, o\u00f9 les<br \/>\ncontrats \u00e0 terme sur les principaux indices sugg\u00e8rent une<br \/>\nouverture inchang\u00e9e pour le Dow Jones<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/%24INDU\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  .DJI<br \/>\n <\/a><br \/>\n et une l\u00e9g\u00e8re<br \/>\nbaisse de 0,05% pour le Standard &amp; Poor&rsquo;s-500<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/%24INX\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  .SPX<br \/>\n <\/a><br \/>\n et de 0,07%<br \/>\npour le Nasdaq.\n<\/p>\n<p>\n * ELI LILLY<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/LLY\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  LLY.N<br \/>\n <\/a><br \/>\n &#8211; Le laboratoire danois Novo Nordisk\n<\/p>\n<p>\n <a href=\"https:\/\/www.boursorama.com\/cours\/1uNVOB.L\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  NOVOb.CO<br \/>\n <\/a><br \/>\n , qui cherche \u00e0 regagner le terrain perdu face \u00e0 son<br \/>\nrival am\u00e9ricain Eli Lilly, entend commercialiser son traitement<br \/>\namaigrissant Wegovy sous forme de comprim\u00e9 d\u00e8s janvier dans les<br \/>\npharmacies aux Etats-Unis, apr\u00e8s avoir re\u00e7u lundi l&rsquo;accord de<br \/>\nl&rsquo;autorit\u00e9 am\u00e9ricaine des m\u00e9dicaments (FDA) pour cette forme<br \/>\nd&rsquo;administration. En avant-Bourse, Eli Lilly recule de 1,1%.\n<\/p>\n<p>\n * NETFLIX<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/NFLX\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  NFLX.O<br \/>\n <\/a><br \/>\n , PARAMOUNT SKYDANCE<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/PSKY\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  PSKY.O<br \/>\n <\/a><br \/>\n , WARNER<br \/>\nBROS DISCOVERY<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/WBD\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  WBD.O<br \/>\n <\/a><br \/>\n , ORACLE<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/ORCL\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  ORCL.N<br \/>\n <\/a><br \/>\n &#8211; La nouvelle offre<br \/>\npublique d&rsquo;achat de Paramount Skydance sur Warner Bros<br \/>\nDiscovery, avec notamment une garantie personnelle de 40,4<br \/>\nmilliards du cofondateur d&rsquo;Oracle, Larry Ellison, reste<br \/>\ninsuffisante, a d\u00e9clar\u00e9 \u00e0 Reuters un actionnaire majeur. Le<br \/>\nconseil d&rsquo;administration de Warner Bros a recommand\u00e9 \u00e0<br \/>\nl&rsquo;unanimit\u00e9, mercredi, de privil\u00e9gier l&rsquo;offre de Netflix.\n<\/p>\n<p>\n * HUNTINGTON INGALLS<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/HII\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  HII.N<br \/>\n <\/a><br \/>\n &#8211; Le constructeur naval<br \/>\nmilitaire am\u00e9ricain bondit de plus de 5% en avant-Bourse apr\u00e8s<br \/>\nque le pr\u00e9sident Donald Trump a fait \u00e9tat de projets pour une<br \/>\nnouvelle classe de navires portant son nom, qui seraient selon<br \/>\nlui, plus grands, plus rapides et \u00ab\u00a0100 fois plus puissants\u00a0\u00bb que<br \/>\ntous ceux qui ont \u00e9t\u00e9 construits pr\u00e9c\u00e9demment.\n<\/p>\n<p>\n * SECTEUR AURIF\u00c8RE &#8211; En avant-Bourse HARMONY GOLD MINING\n<\/p>\n<p>\n <a href=\"https:\/\/www.boursorama.com\/cours\/HMY\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  HMY.N<br \/>\n <\/a><br \/>\n , HECLA MINING<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/HL\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  HL.N<br \/>\n <\/a><br \/>\n et ENDEAVOUR SILVER<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/EXK\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  EXK.N<br \/>\n <\/a><br \/>\n prennent de 1,5% \u00e0 2,1% alors que le cours de l&rsquo;or<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/_GC\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  XAU=<br \/>\n <\/a><br \/>\n a<br \/>\ntouch\u00e9 mardi un niveau record, fr\u00f4lant la barre des 4.500<br \/>\ndollars l&rsquo;once, sur fond de faiblesse du dollar et d&rsquo;incertitude<br \/>\ng\u00e9opolitique persistante.\n<\/p>\n<p>\n * SECTEUR DE L&rsquo;IA &#8211; John Carreyrou, journaliste<br \/>\nd&rsquo;investigation au New York Times et connu pour avoir r\u00e9v\u00e9l\u00e9 des<br \/>\nfraudes au sein de la start-up Theranos, a port\u00e9 plainte lundi<br \/>\navec cinq autres auteurs contre xAI, Anthropic, Google (filiale<br \/>\nd&rsquo;ALPHABET<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/GOOGL\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  GOOGL.O<br \/>\n <\/a><br \/>\n ), OpenAI, META PLATFORMS<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/META\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  META.O<br \/>\n <\/a><br \/>\n et<br \/>\nPerplexity pour avoir utilis\u00e9 sans autorisation leurs livres<br \/>\nprot\u00e9g\u00e9s par le droit d&rsquo;auteur afin d&rsquo;entra\u00eener leurs syst\u00e8mes<br \/>\nd&rsquo;intelligence artificielle (IA).\n<\/p>\n<p>\n * D\u00c9TAILLANTS AM\u00c9RICAINS &#8211; Les ventes au d\u00e9tails aux<br \/>\nEtats-Unis ont augment\u00e9 d&rsquo;environ 4% depuis le d\u00e9but de la<br \/>\np\u00e9riode des f\u00eates, les consommateurs jonglant entre des budgets<br \/>\nplus serr\u00e9s et l&rsquo;envie de renouveler leurs appareils et leurs<br \/>\ngarde-robes, selon des chiffres pr\u00e9liminaires publi\u00e9s mardi par<br \/>\nVisa<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/V\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  V.N<br \/>\n <\/a><br \/>\n et Mastercard<br \/>\n <a href=\"https:\/\/www.boursorama.com\/cours\/MA\/\" target=\"_blank\" rel=\"noopener\"><br \/>\n  MA.N<br \/>\n <\/a><br \/>\n .\n<\/p>\n<p>\n (R\u00e9dig\u00e9 par Diana Mandia et Claude Chendjou, \u00e9dit\u00e9 par Kate<br \/>\nEntringer et Augustin Turpin)<\/p>\n","protected":false},"excerpt":{"rendered":"(Actualis\u00e9 avec contrats \u00e0 terme sur indices, cours en avant-Bourse, d\u00e9taillants am\u00e9ricains) Principales valeurs \u00e0 suivre mardi \u00e0&hellip;\n","protected":false},"author":2,"featured_media":609392,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[400,398,408,35,405,33,34,1011,27,403,402,399,404,401,406,407],"class_list":{"0":"post-617953","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economie","8":"tag-action-cac-40","9":"tag-bourse-de-paris","10":"tag-boursorama","11":"tag-business","12":"tag-cotations","13":"tag-economie","14":"tag-economy","15":"tag-fr","16":"tag-france","17":"tag-indices-devises","18":"tag-investir","19":"tag-investissement","20":"tag-marche-boursier","21":"tag-sicav","22":"tag-trackers","23":"tag-warrants"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115769160896503981","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/617953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=617953"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/617953\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/609392"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=617953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=617953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=617953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}